Risks associated with animal-assisted intervention programs: A literature review.

Animal Assisted Therapy / methods Animals Hospitals Humans
Animal-assisted interventions Hospital infection control Hospital-associated infections Zoonotic infections

Journal

Complementary therapies in clinical practice
ISSN: 1873-6947
Titre abrégé: Complement Ther Clin Pract
Pays: England
ID NLM: 101225531

Informations de publication

Date de publication:
May 2020
Historique:
received: 17 02 2020
accepted: 12 03 2020
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 7 10 2020
Statut: ppublish

Résumé

The benefits of animal-assisted interventions (AAI), to utilize companion animals as an adjunctive treatment modality, is well-established and a burgeoning research field. However, few studies have evaluated the potential hazards of these programs, such as the potential for therapy animals to transfer hospital-associated pathogens between individuals and the hospital environment. Here we review the current literature on the possible risks of hospital-based AAI programs, including zoonotic pathogen transmission. We identified twenty-nine articles encompassing reviews of infection control guidelines and epidemiological studies on zoonotic pathogen prevalence in AAI. We observed substantial heterogeneity in infection control practices among hospital AAI programs. Few data confirmed pathogen transmission between therapy animals and patients. Given AAI's known benefits, we recommend that future research utilize a One Health framework to evaluate microbial dynamics among therapy animals, patients, and hospital environments. This framework may best promote safe practices to ensure the sustainability of these valuable AAI programs.

Identifiants

DOI: 10.1016/j.ctcp.2020.101145 PMID: 32379677 PMC: PMC7673300
pubmed: 32379677
pii: S1744-3881(20)30231-0
doi: 10.1016/j.ctcp.2020.101145
pmc: PMC7673300
mid: NIHMS1579154
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

101145

Subventions

Organisme : NIH HHS
ID : K01 OD019918
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD097692
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008428
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors declare any conflict of interest.

Références

Front Vet Sci. 2018 Feb 12;5:14
pubmed: 29484301
MMWR Recomm Rep. 2003 Jun 6;52(RR-10):1-42
pubmed: 12836624
BMC Complement Altern Med. 2017 Jul 10;17(1):358
pubmed: 28693538
Ecohealth. 2015 Dec;12(4):560-2
pubmed: 26063040
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1367-1373
pubmed: 27609491
CMAJ. 2015 Nov 3;187(16):1236
pubmed: 26527834
Emerg Infect Dis. 2006 Jun;12(6):1036-7
pubmed: 16752477
Am J Infect Control. 2006 Jun;34(5):301-7
pubmed: 16765210
J Pediatr Oncol Nurs. 2017 Sep/Oct;34(5):331-341
pubmed: 28614971
Evid Based Complement Alternat Med. 2006 Sep;3(3):379-83
pubmed: 16951723
Am J Infect Control. 2017 Aug 1;45(8):883-887
pubmed: 28673680
Zoonoses Public Health. 2008 Oct;55(8-10):470-80
pubmed: 18811908
South Med J. 2016 Mar;109(3):154-7
pubmed: 26954652
Zoonoses Public Health. 2010 May;57(3):220-6
pubmed: 20042067
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Can Vet J. 1993 Sep;34(9):549-51
pubmed: 17424285
Infect Control Hosp Epidemiol. 2004 Jan;25(1):5-6
pubmed: 14756211
J Hosp Infect. 2005 Jun;60(2):186-8
pubmed: 15866022
Complement Ther Med. 2014 Apr;22(2):371-90
pubmed: 24731910
Infect Control Hosp Epidemiol. 2013 May;34(5):449-52
pubmed: 23571359
Am J Infect Control. 2008 Mar;36(2):78-85
pubmed: 18313508
Front Vet Sci. 2020 Feb 07;7:35
pubmed: 32118059
Front Vet Sci. 2019 Jun 04;6:167
pubmed: 31214606
Infect Control Hosp Epidemiol. 2006 Jul;27(7):754-8
pubmed: 16807853
J Hosp Infect. 2000 Sep;46(1):4-11
pubmed: 11023717
J Am Vet Med Assoc. 2009 Jun 1;234(11):1404-17
pubmed: 19480620
Eur J Integr Med. 2016 Oct;8(5):695-706
pubmed: 32362955
Am J Infect Control. 2001 Jun;29(3):178-86
pubmed: 11391280
J Hosp Infect. 2006 Apr;62(4):458-66
pubmed: 16466831
J Hosp Infect. 2009 Jul;72(3):268-9
pubmed: 19329224
J Clin Nurs. 2002 Jul;11(4):444-56
pubmed: 12100640
Infect Control Hosp Epidemiol. 2015 May;36(5):495-516
pubmed: 25998315

Auteurs

Kathryn R Dalton (KR)

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore, MD, USA. Electronic address: kdalton4@jhu.edu.

Kaitlin B Waite (KB)

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore, MD, USA.

Kathy Ruble (K)

Johns Hopkins University School of Medicine, Department of Pediatric Oncology, Baltimore, MD, USA.

Karen C Carroll (KC)

Johns Hopkins University School of Medicine, Department of Pathology, Division of Medical Microbiology, Baltimore, MD, USA.

Alexandra DeLone (A)

Johns Hopkins University School of Medicine, Department of Pediatric Oncology, Baltimore, MD, USA.

Pam Frankenfield (P)

Johns Hopkins University School of Medicine, Department of Pediatric Oncology, Baltimore, MD, USA.

James A Serpell (JA)

University of Pennsylvania School of Veterinary Medicine, Department of Clinical Sciences & Advanced Medicine, Philadelphia, PA, USA.

Roland J Thorpe (RJ)

Johns Hopkins University Bloomberg School of Public Health, Department of Health, Behavior and Society, Baltimore, MD, USA.

Daniel O Morris (DO)

University of Pennsylvania School of Veterinary Medicine, Department of Clinical Sciences & Advanced Medicine, Philadelphia, PA, USA.

Jacqueline Agnew (J)

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore, MD, USA.

Ronald C Rubenstein (RC)

The Children's Hospital of Philadelphia, Cystic Fibrosis Center, Philadelphia, PA, USA; The University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, Philadelphia, PA, USA.

Meghan F Davis (MF)

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore, MD, USA; Johns Hopkins Medicine, Department of Molecular and Comparative Pathobiology, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Réadaptation › Thérapie assistée par l'animal › Risks associated with animal-assisted...
questionsmedicales.fr › Eucaryotes › Animaux › Risks associated with animal-assisted...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Hôpitaux › Risks associated with animal-assisted...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Risks associated with animal-assisted...